The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Cold agglutinin disease
Abstract
Cold agglutinin disease is a rare and poorly understood disorder affecting 15% of patients with autoimmune hemolytic anemia. We reviewed the clinical and pathologic features, prognosis, and management in the literature and describe our institutional experience to improve strategies for accurate diagnosis and treatment. Retrospective analysis identified 89 patients from our institution with cold agglutinin disease from 1970 through 2012. Median age at symptom onset was 65 years (range, 41 to 83 years), whereas the median age at diagnosis was 72 years (range, 43 to 91 years). Median survival of all patients was 10.6 years, and 68 patients (76%) were alive 5 years after the diagnosis. The most common symptom was acrocyanosis (n = 39 [44%]), and many had symptoms triggered by cold (n = 35 [39%]) or other factors (n = 20 [22%]). An underlying hematologic disorder was detected in 69 patients (78%). Thirty-six patients (40%) received transfusions during their disease course, and 82% received drug therapy. Rituximab was associated with the longest response duration (median, 24 months) and the lowest proportion of patients needing further treatment (55%). Our institution’s experience and review of the literature confirms that early diagnostic evaluation and treatment improves outcomes in cold agglutinin disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of monoclonal gammopathy of undetermined significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., Offord, J. R., Dispenzieri, A., Katzmann, J. A., & Melton, L. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054494 · Cited by 1,423 · cited 12×
“%) required treatment of CAD.”
BackgroundInfluentialOwen, R. G., Treon, S. P., Al-Katib, A., Fonseca, R., Greipp, P. R., McMaster, M. L., Morra, E., Pangalis, G. A., San Miguel, J. F., Branagan, A. R., et al. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50082 · Cited by 924
Nelson Textbook of Pediatrics,
NAZARIAN, L. F. (1976) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1976.02120060116029 · Cited by 745
Gehrs, B. C., & Friedberg, R. C. (2002) · American Journal of Hematology · doi:10.1002/ajh.10062 · Cited by 647
Merlini, G., & Stone, M. J. (2006) · Blood · doi:10.1182/blood-2006-03-001164 · Cited by 463
Bida, J. P., Kyle, R. A., Therneau, T. M., Melton, L. J., Plevak, M. F., Larson, D. R., Dispenzieri, A., Katzmann, J. A., & Rajkumar, S. V. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.8.685 · Cited by 202
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients
Schöllkopf, C., Kjeldsen, L., Bjerrum, O. W., Mourits-Andersen, H. T., Nielsen, J. L., Christensen, B. E., Jensen, B. A., Pedersen, B. B., Taaning, E. B., Klausen, T. W., et al. (2006) · Leukemia & Lymphoma · doi:10.1080/10428190500286481 · Cited by 175
Dacie, J. V. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00016 · Cited by 152
The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
Jaffe, C. J., Atkinson, J. P., & Frank, M. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108547 · Cited by 128
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease
Röth, A., Hüttmann, A., Rother, R. P., Dührsen, U., & Philipp, T. (2009) · Blood · doi:10.1182/blood-2009-01-196329 · Cited by 112
Cited by
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. D. O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01620-2 · Cited by 4,004
Jäger, U., Barcellini, W., Broome, C. M., Gertz, M. A., Hill, A., Hill, Q. A., Jilma, B., Kuter, D. J., Michel, M., Montillo, M., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2019.100648 · Cited by 565
Self-citationBarcellini, W., Fattizzo, B., Zaninoni, A., Radice, T., Nichele, I., Di Bona, E., Lunghi, M., Tassinari, C., Alfinito, F., Ferrari, A., et al. (2014) · Blood · doi:10.1182/blood-2014-06-583021 · Cited by 382
Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
Fermand, J.-P., Bridoux, F., Dispenzieri, A., Jaccard, A., Kyle, R. A., Leung, N., & Merlini, G. (2018) · Blood · doi:10.1182/blood-2018-04-839480 · Cited by 299
Metadata
- Authors
- Swiecicki, P. L., Hegerova, L. T., & Gertz, M. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-08-15
- Volume
- 122
- Issue
- 7
- Pages
- 1114-1121
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1963996170
- Cited by
- 324
- References
- 17
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cold agglutinin disease. https://app.cochat.ai/papers/10.1182/blood-2013-02-474437
- The paper
- Swiecicki, P. L., Hegerova, L. T., & Gertz, M. A. (2013). Cold agglutinin disease. Blood. https://doi.org/10.1182/blood-2013-02-474437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.